Journal of Drug Assessment
Volume 11, 2022 - Issue 1
Open access
2,116
Views
2
CrossRef citations to date
0
Altmetric
Transplants
A review of the risks of long-term consequences associated with components of the CHOP chemotherapy regimen
Crystal Watsona Atara Biotherapeutics Inc., South San Francisco, CA, USACorrespondence[email protected]
https://orcid.org/0000-0001-8763-9197
, https://orcid.org/0000-0001-8763-9197
Hemanth Gadikotab Maple Health Group LLC, New York, NY, USA
, Arie Barleva Atara Biotherapeutics Inc., South San Francisco, CA, USA
& Rachel Beckermanb Maple Health Group LLC, New York, NY, USA
Pages 1-11
|
Received 27 Dec 2021, Accepted 29 Apr 2022, Published online: 03 Jun 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.